-
Sanofi: Targeted therapy drug for chronic obstructive pulmonary disease (COPD), Dabitou, approved in China
On September 27th, Sanofi announced that Dapitumab Injection has been approved by the China National Medical Products Administration for use in adult patients with chronic obstructive pulmonary disea ... -
The targeted therapy drug for chronic obstructive pulmonary disease, Dabitou, has been approved in China
Southern Finance and Economics, September 27th - Sanofi announced that Dabitou& reg; Dupilumab injection has been approved by the National Medical Products Administration (NMPA) of China for use in a ... -
Sanofi's targeted therapy drug for chronic obstructive pulmonary disease, Dabitou, has been approved in China
On September 27th, Sanofi announced that Dapitumab Injection has been approved by the China National Medical Products Administration for use in adult patients with chronic obstructive pulmonary disea ... -
Tianjing Biotechnology grants Sanofi the rights to Yulelimab in China with a down payment of 250 million yuan
Beijing News Tianjing Biotech announced on its official WeChat official account on September 25 that it had reached strategic cooperation with Sanofi on the development, production and commercializat ... -
Mercedes Benz invests another 14 billion yuan to deepen its layout in China and enrich its "Made in China" product lineup with "Chinese speed"
Mercedes Benz invests another 14 billion yuan to deepen its layout in China and enrich its "Made in China" product lineup at a "Chinese speed". On September 4th, Ola Klenius, Chairman of the Board of ... -
It is reported that Tesla plans to start producing a six seater version of the Model Y in China by the end of 2025
According to sources, Tesla plans to start producing the six seater version of the Model Y in China by the end of 2025. -
General Motors China responds to rumors of layoffs and capacity cuts: all business in China is high-quality assets
Recently, it was reported that General Motors is cutting personnel in relevant departments in the Chinese market, including the research and development department. In the coming weeks, General Motor ... -
Pfizer's new hemophilia treatment drug Mataximab's application for market launch in China has been accepted
On August 13th, the official website of the Drug Evaluation Center (CDE) of the China National Medical Products Administration (NMPA) announced that the Class 1 therapeutic biological product Mataxim ... -
Starbucks needs to find partners as revenue in China declines year-on-year
Starbucks is facing increasing growth pressure. On July 31st, the company released its performance for the third quarter of fiscal year 2024 (ending on June 30th, 2024). According to the financial re ... -
Jike Motors and Israeli autonomous driving company Mobileye will accelerate localization of technology in China
Jike Motors and Israeli autonomous driving company Mobileye will accelerate technology localization in China. On August 1st, Jike Motors and Israeli autonomous driving technology company Mobileye ann ... -
Price increase slows down! Procter&Gamble 2024 Financial Report: Expected to Achieve Median Growth in Business Performance in China
On July 30th, US time, Procter&Gamble (P&G) announced its Q4 and fiscal year 2024 results. Driven by price increases, Procter&Gamble's net sales and net profit attributable to shareholders for fiscal ... -
After Nissan, another Japanese brand plans to close two vehicle factories in China
21st Century Business Herald reporter Song Doudou reports Japanese brands, whose market share in China continues to decline, hope to pass the critical moment of "dilemma" by closing factories and "sl ... -
Merck's small molecule cancer drug, acquired for over $1.3 billion, launches Phase 3 clinical trials in China
According to the latest announcement on the Chinese Drug Clinical Trial Registration and Information Disclosure Platform, Merck's Class 1 oral drug MK-3543 (bomedemstat) for the treatment of primary ... -
Tesla Musk: Expected FSD to be approved and implemented in China before the end of the year
Shanghai Securities News (reporter Yu Liyan) Elon Musk, the founder and CEO of Tesla, mentioned on the Tesla financial report conference call held on July 24 that he would apply for regulatory approv ... -
Johnson&Johnson's revenue of $43.83 billion in the first half of the year is seeking new growth points through a "change of leadership" in China
In the first half of this year, Johnson&Johnson was one of the multinational pharmaceutical companies (MNCs) that released financial reports earlier. On July 15th, Johnson&Johnson China announced tha ...- worrysorry2017
- 2024-7-20 11:02
- 支持
- 反对
- 回复
- 收藏
-
MNC interim report scan | Johnson&Johnson's revenue of $43.83 billion in the first half of the year seeks new growth points in China through 'changing leadership'
In the first half of this year, Johnson&Johnson was one of the multinational pharmaceutical companies (MNCs) that released financial reports earlier. On July 15th, Johnson&Johnson China announced tha ...- happyguy123
- 2024-7-18 20:14
- 支持
- 反对
- 回复
- 收藏
-
Over 1 million chips will be shipped! Nvidia's sales in China are expected to reach 12 billion US dollars this year
On July 4th, SemiAnalysis, a chip consulting firm, estimated that Nvidia is expected to sell artificial intelligence chips worth approximately $12 billion in China this year. Huang Renxun once expres ... -
Johnson&Johnson Long acting Schizophrenic Therapy Approved in China
Johnson&Johnson's long-acting schizophrenia therapy has been approved in China. Johnson&Johnson announced that its long-acting injection, Shanjiuda, which is administered every six months, has recent ... -
Honda's sales in China from January to May decreased by 16.7% year-on-year, with 346940 vehicles sold
Honda China announced on June 5th that its cumulative sales of terminal vehicles in China in May 2024 were 66202 units; From January to May, Honda's cumulative sales of terminal cars in China were 34 ... -
Boeing China President Liu Qing: "Made in China" Supports Supply Chain Stability with Over 35 Direct Suppliers in China
On June 4th, Liu Qing, President of Boeing China, issued a statement stating that "Made in China" supports Boeing's supply chain stability. Liu Qing stated that she visited several of Boeing's major ...